Antibody Actions
Affinity and Avidity
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Jingzhou Wang1,2,3, Aiden J Aceves1,4, Nicholas J Friesenhahn2
1Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, United States.
We developed CDR-extended antibodies (CDRxAbs), a novel class of molecular agents. These bioconjugates enhance small molecule binding affinity and specificity to targets.
11:02Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
Published on: September 14, 2018
09:39Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics DCAF
Published on: September 17, 2019
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: